David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon

Analyst Articles

Among the biggest winners in Monday’s early trading are Peregrine Pharmaceutical (Nasdaq: PPHM) and Century Aluminum (Nasdaq: CENX). The key to find winning investments in biotech: focus on companies that can handily exceed the increasingly stringent restrictions placed on Phase II trials. As noted in today’s look at falling… Read More

Among the biggest losers in Monday’s early trading are Titan Machinery (Nasdaq: TITN) and Geron (nasdaq: GERN). The drought of 2012 is just starting to show up in quarterly reports, and investors are in no mood to take the long view:  Drought-related profit… Read More

If you’re like me, then you’ve grown dependent on a digital video recorder (DVR) for your evening’s entertainment. The ability to store hours of my favorite shows — and access them instantly — was only hinted at when video-tape recorders (VCRs) were first introduced in the 1980s.  But as it… Read More

Among the biggest winners in Friday’s early trading are Smith & Wesson (Nasdaq: SWHC) and Cooper Cos. (NYSE: COO).   Soon after President Obama took office, gun sellers did a brisk amount of business on fears that firearms laws would soon become more restrictive. This chart of… Read More